Our data indicated that ZEB1 expression is lost in a significant number of glioma patients, and that the cause of ZEB1 loss is due in large part to heterozygous deletions in both GBMs and lower grade gliomas with frequent LOH in at least 20% of glioma patients. This evidence concerns the gene ZEB1 and glioma.